A phase 2 clinical study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a fetal hemoglobin inducer, in patients with sickle cell disease

Authors
Category Primary study
JournalBlood
Year 2011
This article has no abstract
Epistemonikos ID: 1278700e71c965d739737970e4bb6abc66e8db48
First added on: Feb 05, 2025